Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Magnetic Resonance Imaging of Hidradenitis Suppurativa: A Focus on the Anoperineal Location

  • Received : 2022.04.01
  • Accepted : 2022.05.24
  • Published : 2022.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease involving apocrine-bearing sites. It is characterized by recurrent painful nodules and abscesses that potentially rupture, resulting in sinus tract formation, fistulas, and scarring. HS tends to be found in the intertriginous areas (i.e., the axillary, inguinal, and perianal areas of the body). HS may be uncommon for radiologists because its diagnosis is usually based on clinical assessment. However, diagnosis based solely on clinical manifestations can underestimate the severity of HS. Ultrasonography and MRI play a critical adjunct role in determining the severity and extent of the disease and greatly aid its management. Given that MRI is an effective imaging tool, its role in the analysis of severe and anogenital HS lesions merits considerable attention. Unfortunately, anoperineal HS imposes diagnostic dilemmas. It has multiple symptoms and presentations and often mimics other diseases in the intertriginous areas. Therefore, a thorough understanding of HS is essential to avoid delayed diagnoses. This review highlights the typical MRI imaging features and staging of HS, emphasizing on the anoperineal location. The review also differentiates the disease from mimics to facilitate the prompt delivery of appropriate treatment and improve patients' quality of life.

Keywords

References

  1. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009;60:539-561; quiz 562-563  https://doi.org/10.1016/j.jaad.2008.11.911
  2. Kurzen H, Kurokawa I, Jemec GB, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, et al. What causes hidradenitis suppurativa? Exp Dermatol 2008;17:455-456; discussion 457-472  https://doi.org/10.1111/j.1600-0625.2008.00712_1.x
  3. Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, et al. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med 2012;157:846-855  https://doi.org/10.7326/0003-4819-157-12-201212180-00004
  4. von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001;144:809-813  https://doi.org/10.1046/j.1365-2133.2001.04137.x
  5. van der Zee HH, van der Woude CJ, Florencia EF, Prens EP. Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study. Br J Dermatol 2010;162:195-197  https://doi.org/10.1111/j.1365-2133.2009.09430.x
  6. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008;59:596-601  https://doi.org/10.1016/j.jaad.2008.06.020
  7. Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996;35(2 Pt 1):191-194  https://doi.org/10.1016/S0190-9622(96)90321-7
  8. Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015;29:619-644  https://doi.org/10.1111/jdv.12966
  9. Hurley H. Dermatologic surgery, principles and practice. New York: Marcel Dekker, 1989:729-739 
  10. Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009;61:51-57  https://doi.org/10.1016/j.jaad.2009.02.013
  11. Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009;161:831-839  https://doi.org/10.1111/j.1365-2133.2009.09198.x
  12. Wortsman X, Moreno C, Soto R, Arellano J, Pezo C, Wortsman J. Ultrasound in-depth characterization and staging of hidradenitis suppurativa. Dermatol Surg 2013;39:1835-1842  https://doi.org/10.1111/dsu.12329
  13. Wortsman X. Imaging of hidradenitis suppurativa. Dermatol Clin 2016;34:59-68  https://doi.org/10.1016/j.det.2015.08.003
  14. Griffin N, Williams AB, Anderson S, Irving PM, Sanderson J, Desai N, et al. Hidradenitis suppurativa: MRI features in anogenital disease. Dis Colon Rectum 2014;57:762-771  https://doi.org/10.1097/DCR.0000000000000131
  15. Aduful H, Paintsil A. Extensive groin and perineal hidradenitis suppurativa complicated by high fistula in ano. Ghana Med J 2007;41:30-32 
  16. Hana A, Booken D, Henrich C, Gratchev A, Maas-Szabowski N, Goerdt S, et al. Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci 2007;80:2214-2220  https://doi.org/10.1016/j.lfs.2007.02.007
  17. Schlapbach C, Hanni T, Yawalkar N, Hunger RE. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol 2011;65:790-798  https://doi.org/10.1016/j.jaad.2010.07.010
  18. Yazdanyar S, Miller IM, Jemec GB. Hidradenitis suppurativa and Crohn's disease: two cases that support an association. Acta Dermatovenerol Alp Pannonica Adriat 2010;19:23-25 
  19. Haggett PJ, Moore NR, Shearman JD, Travis SP, Jewell DP, Mortensen NJ. Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging. Gut 1995;36:407-410  https://doi.org/10.1136/gut.36.3.407
  20. Monnier L, Dohan A, Amara N, Zagdanski AM, Drame M, Soyer P, et al. Anoperineal disease in hidradenitis suppurativa : MR imaging distinction from perianal Crohn's disease. Eur Radiol 2017;27:4100-4109  https://doi.org/10.1007/s00330-017-4776-1
  21. Heo SH, Shin SS, Kim JW, Lim HS, Seon HJ, Jung SI, et al. Imaging of actinomycosis in various organs: a comprehensive review. Radiographics 2014;34:19-33  https://doi.org/10.1148/rg.341135077
  22. Safioleas M, Stamatakos M, Mouzopoulos G, Diab A, Kontzoglou K, Papachristodoulou A. Fournier's gangrene: exists and it is still lethal. Int Urol Nephrol 2006;38:653-657  https://doi.org/10.1007/s11255-005-2946-6
  23. Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. Radiographics 2008;28:519-528  https://doi.org/10.1148/rg.282075048
  24. Lin MP, Chen YL, Cheng JT, Lu CL. Early signs of Fournier gangrene: radiological characteristics. Radiol Diagnos Imaging 2018;2:1-6  https://doi.org/10.15761/RDI.1000139
  25. Hamoir XL, Francois RJ, Van den Haute V, Van Campenhoudt M. Arthritis and hidradenitis suppurativa diagnosed in a 48-year-old man. Skeletal Radiol 1999;28:453-456  https://doi.org/10.1007/s002560050545
  26. Slade DE, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 2003;56:451-461  https://doi.org/10.1016/S0007-1226(03)00177-2
  27. Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 1999;40:73-76  https://doi.org/10.1016/S0190-9622(99)70530-X
  28. van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol 2010;63:475-480  https://doi.org/10.1016/j.jaad.2009.12.018
  29. Kelly AM, Cronin P. MRI features of hidradenitis suppurativa and review of the literature. AJR Am J Roentgenol 2005;185:1201-1204 https://doi.org/10.2214/AJR.04.1233